These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8479116

  • 21. Long-term erythropoietin in rats with reduced renal mass.
    Torralbo A, Blanco J, Fontanellas A, Herrero JA, Cruceyra A, González-Lŏpez P, Barrientos A.
    Nephron; 1996; 73(2):280-5. PubMed ID: 8773356
    [Abstract] [Full Text] [Related]

  • 22. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.
    Anderson S, Meyer TW, Rennke HG, Brenner BM.
    J Clin Invest; 1985 Aug; 76(2):612-9. PubMed ID: 2993362
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the effects of calcium antagonists and converting enzyme inhibitors on renal function under normal and hypertensive conditions.
    Romero JC, Ruilope LM, Bentley MD, Fiksen-Olsen MJ, Lahera V, Vidal MJ.
    Am J Cardiol; 1988 Oct 05; 62(11):59G-68G. PubMed ID: 3051997
    [Abstract] [Full Text] [Related]

  • 24. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A.
    Ann Acad Med Stetin; 1999 Oct 05; Suppl 52():1-93. PubMed ID: 10589103
    [Abstract] [Full Text] [Related]

  • 25. Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats.
    Véniant M, Heudes D, Clozel JP, Bruneval P, Ménard J.
    Kidney Int; 1994 Aug 05; 46(2):421-9. PubMed ID: 7967354
    [Abstract] [Full Text] [Related]

  • 26. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
    Jackson B, Cubela R, Debrevi L, Whitty M, Johnston CI.
    J Cardiovasc Pharmacol; 1987 Aug 05; 10 Suppl 10():S167-9. PubMed ID: 2455124
    [Abstract] [Full Text] [Related]

  • 27. Effects of nifedipine and enalapril on glomerular injury in rats with deoxycorticosterone-salt hypertension.
    Dworkin LD, Levin RI, Benstein JA, Parker M, Ullian ME, Kim Y, Feiner HD.
    Am J Physiol; 1990 Oct 05; 259(4 Pt 2):F598-604. PubMed ID: 2221099
    [Abstract] [Full Text] [Related]

  • 28. Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model.
    Raij L, Chiou XC, Owens R, Wrigley B.
    Am J Med; 1985 Sep 27; 79(3C):37-41. PubMed ID: 2996345
    [Abstract] [Full Text] [Related]

  • 29. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.
    Ziai F, Ots M, Provoost AP, Troy JL, Rennke HG, Brenner BM, Mackenzie HS.
    Kidney Int Suppl; 1996 Dec 27; 57():S132-6. PubMed ID: 8941934
    [Abstract] [Full Text] [Related]

  • 30. Angiotensin-converting enzyme inhibition in the prevention and treatment of chronic renal damage in the hypertensive fawn-hooded rat.
    Verseput GH, Provoost AP, Braam BB, Weening JJ, Koomans HA.
    J Am Soc Nephrol; 1997 Feb 27; 8(2):249-59. PubMed ID: 9048344
    [Abstract] [Full Text] [Related]

  • 31. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.
    Adamczak M, Gross ML, Krtil J, Koch A, Tyralla K, Amann K, Ritz E.
    J Am Soc Nephrol; 2003 Nov 27; 14(11):2833-42. PubMed ID: 14569093
    [Abstract] [Full Text] [Related]

  • 32. The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor.
    Jackson B, Johnston CI.
    J Hypertens; 1988 Jun 27; 6(6):495-501. PubMed ID: 2842393
    [Abstract] [Full Text] [Related]

  • 33. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat.
    Krivosíková Z, Sebeková K, Spustová V, Lajdová I, Dzúrik R.
    Physiol Res; 1999 Jun 27; 48(6):429-35. PubMed ID: 10783907
    [Abstract] [Full Text] [Related]

  • 34. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
    Noda M, Fukuda R, Matsuo T, Ohta M, Nagano H, Imura Y, Nishikawa K, Shibouta Y.
    Kidney Int Suppl; 1997 Dec 27; 63():S136-9. PubMed ID: 9407442
    [Abstract] [Full Text] [Related]

  • 35. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
    Kanazawa M, Kawamura T, Li L, Sasaki Y, Matsumoto K, Kataoka H, Ito O, Minami N, Sato T, Ootaka T, Kohzuki M.
    Am J Hypertens; 2006 Jan 27; 19(1):80-6. PubMed ID: 16461196
    [Abstract] [Full Text] [Related]

  • 36. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct 27; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 37. Angiotensin-converting enzyme inhibition attenuates hypercholesterolemia and glomerular injury in hyperlipidemic Imai rats.
    Sakemi T, Baba N, Yoshikawa Y.
    Nephron; 1992 Oct 27; 62(3):315-21. PubMed ID: 1436345
    [Abstract] [Full Text] [Related]

  • 38. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
    Lafayette RA, Mayer G, Park SK, Meyer TW.
    J Clin Invest; 1992 Sep 27; 90(3):766-71. PubMed ID: 1522231
    [Abstract] [Full Text] [Related]

  • 39. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure.
    Okada K, Okawa E, Shibahara H, Maruyama T, Maruyama N, Matsumoto K, Takahashi S.
    Kidney Blood Press Res; 2004 Sep 27; 27(4):218-25. PubMed ID: 15273424
    [Abstract] [Full Text] [Related]

  • 40. Effects of calcium channel blockers on experimental glomerular injury.
    Dworkin LD.
    J Am Soc Nephrol; 1990 Sep 27; 1(3 Suppl 1):S21-7. PubMed ID: 16989074
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.